(1S,2R,3S,4R,5S)-4-(6-(3-chlorobenzylamino)-2-(2-(trimethylsilyl)ethynyl)-9H-purin-9-yl)-2,3-dihydroxy-N-methylbicyclo[3.1.0]hexane-1-carboxamide

ID: ALA257405

PubChem CID: 44449058

Max Phase: Preclinical

Molecular Formula: C25H29ClN6O3Si

Molecular Weight: 525.09

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CNC(=O)[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(Cl)c4)nc(C#C[Si](C)(C)C)nc31)[C@H](O)[C@@H]2O

Standard InChI:  InChI=1S/C25H29ClN6O3Si/c1-27-24(35)25-11-16(25)19(20(33)21(25)34)32-13-29-18-22(28-12-14-6-5-7-15(26)10-14)30-17(31-23(18)32)8-9-36(2,3)4/h5-7,10,13,16,19-21,33-34H,11-12H2,1-4H3,(H,27,35)(H,28,30,31)/t16-,19-,20+,21+,25+/m1/s1

Standard InChI Key:  RDYPNVDYKVTREJ-YZSDQEEOSA-N

Molfile:  

     RDKit          2D

 37 41  0  0  1  0  0  0  0  0999 V2000
    1.7751  -21.2558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6002  -21.2558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8570  -20.4716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8225  -20.9082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0943  -20.5202    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8506  -21.7327    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6057  -20.9568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6414  -20.2157    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3518  -22.2351    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0843  -21.9238    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7156  -19.4296    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8906  -19.4307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9715  -20.2139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3030  -20.6976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3884  -21.5163    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1416  -21.8525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8102  -21.3638    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7215  -20.5468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3879  -20.0603    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5225  -20.4716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1846  -19.9891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4357  -19.6571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8109  -19.4522    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    7.1424  -20.3941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8088  -19.9076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5614  -20.2434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2274  -19.7577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1396  -18.9364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3801  -18.6033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7173  -19.0911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9817  -20.0919    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.2286  -22.6730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3153  -23.4910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4052  -24.3098    0.0000 Si  0  0  0  0  0  4  0  0  0  0  0  0
    5.4406  -25.2783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2254  -24.2198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5851  -24.3997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  8  1  1
 17 18  2  0
 18 13  1  0
  1  2  1  0
 18 19  1  0
 21 20  1  0
 22 21  1  0
 20 22  1  0
  1  9  1  6
 20  4  1  1
  2 10  1  6
  8 14  1  0
 21 23  1  1
 19 24  1  0
  4  5  1  0
 24 25  1  0
 13 11  1  0
 25 26  2  0
 11 12  2  0
 26 27  1  0
 12  8  1  0
 27 28  2  0
  2  3  1  0
 28 29  1  0
  4  6  2  0
 29 30  2  0
 30 25  1  0
 13 14  2  0
 27 31  1  0
  3 21  1  0
 16 32  1  0
 14 15  1  0
 32 33  3  0
  5  7  1  0
 33 34  1  0
 15 16  2  0
 34 35  1  0
 20  1  1  0
 34 36  1  0
 16 17  1  0
 34 37  1  0
M  END

Associated Targets(Human)

ADORA1 Tclin Adenosine receptors; A1 & A3 (1051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adora1 Adenosine A1 receptor (162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora3 Adenosine A3 receptor (257 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora2a Adenosine A2a receptor (87 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 525.09Molecular Weight (Monoisotopic): 524.1759AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Melman A, Gao ZG, Kumar D, Wan TC, Gizewski E, Auchampach JA, Jacobson KA..  (2008)  Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists.,  18  (9): [PMID:18424135] [10.1016/j.bmcl.2008.04.001]

Source